COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1012: Articles 10111-10120  | Next

A recurring YYDRxG pattern in broadly neutralizing antibodies to a conserved site on SARS-CoV-2, variants of concern, and related viruses
Liu, H., Kaku, C. I., Song, G., Yuan, M., Andrabi, R., Burton, D. R., Walker, L. M., Wilson, I. A.
10.1101/2021.12.15.472864 — Posted: 2021-12-17
SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
Eales, O., Page, A., de Oliveira Martins, L., Wang, H., Bodinier, B., Haw, D., Jonnerby, J., Atchison, C., The COVID-19 Genomics UK (COG-UK) Consortium, , Ashby, D., Barclay, W., Taylor, G., Cooke, G., Ward, H., Darzi, A., Riley, S., Chadeau-Hyam, M., Donnelly, C. A., Elliott, P.
10.1101/2021.12.17.21267925 — Posted: 2021-12-17
A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients
MARQUETTE, C. H., MARTINUZZI, E., BENZAQUEN, J., GUERIN, O., LEROY, S., SIMON, T., ILIE, M., HOFMAN, V., ALLEGRA, M., TANGA, V., MICHEL, E., BOUTROS, J., MANIEL, C., SICARD, A., GLAICHENHAUS, N., CZERKINSKY, C., BLANCOU, P., HOFMAN, P.
10.1101/2021.12.16.21267932 — Posted: 2021-12-17
Patients' and carers' experiences of, and engagement with remote home monitoring services for COVID-19 patients: a rapid mixed-methods study
Walton, H., Vindrola-Padros, C., Crellin, N., Sidhu, M. S., Herlitz, L., Litchfield, I., Ellins, J., Ng, P. L., Massou, E., Tomini, S. M., Fulop, N. J.
10.1101/2021.12.17.21267968 — Posted: 2021-12-17
Real-world response of COVID-19 patients in Mexico
Gonzalez-Arroyo, G., Gomez Garcia, S., Gomez Garcia, A., Pacifuentes Orozco, A., Gonzalez Orozco, J. G., Garcia Arreola, M., Lopez Lopez, K. G., Ortiz Castillo, T., Or-Geva, N., Moreno-Grau, S., Alvarez Aguilar, C., Bustamante, C. D., Lopez Pineda, A.
10.1101/2021.12.16.21267866 — Posted: 2021-12-17
A machine learning-based approach to determine infection status in recipients of BBV152 whole virion inactivated SARS-CoV-2 vaccine for serological surveys
Singh, P., Ujjainiya, R., Prakash, S., Naushin, S., Sardana, V., Bhatheja, N., Singh, A. P., Barman, J., Kumar, K., Khan, R., Tallapaka, K. B., Anumalla, M., Lahiri, A., Kar, S., Bhosale, V., Srivastava, M., Mugale, M. N., Pandey, C. P., Khan, S., Katiyar, S., Raj, D., Ishteyaque, S., Khanka, S., Rani, A., Promila, , Sharma, J., Seth, A., Dutta, M., Saurabh, N., Veerapandian, M., Venkatachalam, G., Bansal, D., Gupta, D., Halami, P. M., Peddha, M. S., Sundaram, G. M., Veeranna, R. P., Pal, A., Singh, R. K., Anandasadagopan, S. K., Karuppanan, P., Rahman, S. N., Selvakumar, G., Venkatesan, S., Karmakar, M., Sardana, H. K., Kothari, A., Parihar, D., Thakur, A., Saifi, A., Gupta, N., Singh, Y., Reddu, R., Gautam, R., Mishra, A., Mishra, A., Gogeri, I., Rayasam, G., Padwad, Y., Patial, V., Hallan, V., Singh, D., Tirpude, N., Chakrabarti, P., Maity, S. K., Ganguly, D., Sistla, R., Balthu, N. K., A, K. K., Ranjith, S., Kumar, V. B., Jamwal, P. S., Wali, A., Ahmed, S., Chouhan, R., Gandhi, S. G., Sharma, N., Rai, G., Irshad, F., Jamwal, V. L., Paddar, M., Khan, S. U., Malik, F., Ghosh, D., Thakkar, G., Barik, S. K., Tripathi, P., Satija, Y. K., Mohanty, S., Khan, M. T., Subudhi, U., Sen, P., Kumar, R., Bhardwaj, A., Gupta, P., Sharma, D., Tuli, A., Chaudhuri, S. R., Krishnamurthi, S., L, P., Rao, C. V., Singh, B. N., Chaurasiya, A., Chaurasiyar, M., Bhadange, M., Likhitkar, B., Mohite, S., Patil, Y., Kulkarni, M., Joshi, R., Pandya, V., Patil, A., Samson, R., Vare, T., Dharne, M., Giri, A., Paranjape, S., Sastry, G. N., Kalita, J., Phukan, T., Manna, P., Romi, W., Bharali, P., Ozah, D., Sahu, R. K., Dutta, P., Singh, M. G., Gogoi, G., Tapadar, Y. B., Babu, E. V., Sukumaran, R. K., Nair, A. R., Puthiyamadam, A., Valappil, P., Pillai Prasannakumari, A. V., Chodankar, K., Damare, S., Agrawal, V. V., Chaudhary, K., Agrawal, A., Sengupta, S., Dash, D.
10.1101/2021.12.16.21267889 — Posted: 2021-12-17
Genomic epidemiological models describe pathogen evolution across fitness valleys
Cardenas, P., Santos-Vega, M.
10.1101/2021.12.16.473045 — Posted: 2021-12-17
White Matter Beta-Amyloid Precursor Protein Immunoreactivity in Autopsied Subjects With and Without COVID-19
Beach, T. G., DeTure, M., Walker, J. E., Arce, R., Glass, M. J., Sue, L. I., Intorcia, A. J., Nelson, C. M., Suszczewicz, K. E., Borja, C. I., Serrano, G. E., Dickson, D. W.
10.1101/2021.12.16.21266656 — Posted: 2021-12-17
QTQTN motif upstream of the furin-cleavage site plays key role in SARS-CoV-2 infection and pathogenesis.
Vu, M. N., Lokugamage, K., Plante, J. A., Scharton, D., Johnson, B. A., Sotcheff, S., Swetnam, D., Schindewolf, C., Alvarado, R. E., Crocquet-Valdes, P. A., Debbink, K., Weaver, S., Walker, D. H., Routh, A. L., Plante, K. S., Menachery, V. D.
10.1101/2021.12.15.472450 — Posted: 2021-12-17
NFL COVID-19 Return to Sport Injury Prevalence Comparison
Puga, T. B., Schafer, J., Agbedanu, P., Treffer, K.
10.1101/2021.12.16.21267811 — Posted: 2021-12-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).